Despite the importance of the MDM2-MYCN axis in neuroblastoma and retinoblastoma, it has been unclear if MDM2 promotes MYCN expression in additional cancers and if MDM2 also regulates MYC. The gene discussed is MYCN; the disease is retinoblastoma.